⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for tumor recurrence

Every month we try and update this database with for tumor recurrence cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular CarcinomaNCT04499833
Hepatocellular ...
Recurrence Tumo...
liver transplan...
18 Years - 70 YearsCentro Hospitalar de Lisboa Central
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.NCT06022029
Triple Negative...
Diffuse Large B...
Follicular Lymp...
Lymphoma, Non-H...
Mantle Cell Lym...
Bladder Cancer
Uveal Melanoma,...
Cervix Cancer
Carcinoma in Si...
Head and Neck S...
Skin Cancer
Metastatic Canc...
Tumor, Solid
Tumor Recurrenc...
ONM-501
Cemiplimab
18 Years - OncoNano Medicine, Inc.
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.NCT06022029
Triple Negative...
Diffuse Large B...
Follicular Lymp...
Lymphoma, Non-H...
Mantle Cell Lym...
Bladder Cancer
Uveal Melanoma,...
Cervix Cancer
Carcinoma in Si...
Head and Neck S...
Skin Cancer
Metastatic Canc...
Tumor, Solid
Tumor Recurrenc...
ONM-501
Cemiplimab
18 Years - OncoNano Medicine, Inc.
Open-Label Study of TPI 287 for Patients With Metastatic MelanomaNCT01340729
Metastatic Mela...
TPI 287
15 Years - M.D. Anderson Cancer Center
FDG and FDOPA PET Demonstration of Functional Brain AbnormalitiesNCT04315584
Glioblastoma
Positron Emissi...
Computed Tomogr...
Multiparametric...
Fludeoxyglucose...
fluorine F 18 f...
18 Years - University of Virginia
HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular CarcinomaNCT04499833
Hepatocellular ...
Recurrence Tumo...
liver transplan...
18 Years - 70 YearsCentro Hospitalar de Lisboa Central
Open-Label Study of TPI 287 for Patients With Metastatic MelanomaNCT01340729
Metastatic Mela...
TPI 287
15 Years - M.D. Anderson Cancer Center
Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological MalignanciesNCT05457595
Tumor Recurrenc...
Malignant Epith...
Malignant Epith...
Malignant Epith...
carbon ion radi...
18 Years - CNAO National Center of Oncological Hadrontherapy
Outcome Analysis of Aspirin in Liver TransplantationNCT04327427
Liver Transplan...
Aspirin
18 Years - University of Zurich
HOPE to Reduce Tumour Recurrence After LT In Patients With HCCNCT05876052
Liver Cancer
Tumor Recurrenc...
Hepatocellular ...
Liver Transplan...
Ex-vivo Hypothe...
Hypothermic oxy...
18 Years - University of Bologna
Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular CarcinomaNCT03515369
Hepatocellular ...
Tumor Recurrenc...
Babaodan oral c...
Placebo oral ca...
18 Years - 75 YearsEastern Hepatobiliary Surgery Hospital
The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder CancerNCT05704231
Non-Muscle Inva...
Self Efficacy
Smoking Behavio...
Tumor Recurrenc...
Progression, Di...
Behavioral: Mot...
21 Years - Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Clinical Study on the Re-irradiation of Lateral Pelvic Recurrences of Gynecological MalignanciesNCT05457595
Tumor Recurrenc...
Malignant Epith...
Malignant Epith...
Malignant Epith...
carbon ion radi...
18 Years - CNAO National Center of Oncological Hadrontherapy
Chemoradiation vs Immunotherapy and Radiation for Head and Neck CancerNCT03383094
Head and Neck S...
Cancer
Cancer of Head ...
Cancer, Advance...
Cancer, Metasta...
Tumor
Tumor Recurrenc...
Tumor Neck
Tumor Metastasi...
Oral Cancer
Oropharyngeal C...
Oropharynx Canc...
Oropharynx Canc...
Oropharynx Canc...
Oropharynx Canc...
Pembrolizumab
Radiation thera...
Cisplatin
18 Years - University of California, San Diego
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.NCT06022029
Triple Negative...
Diffuse Large B...
Follicular Lymp...
Lymphoma, Non-H...
Mantle Cell Lym...
Bladder Cancer
Uveal Melanoma,...
Cervix Cancer
Carcinoma in Si...
Head and Neck S...
Skin Cancer
Metastatic Canc...
Tumor, Solid
Tumor Recurrenc...
ONM-501
Cemiplimab
18 Years - OncoNano Medicine, Inc.
Safety and Efficacy Evaluation of Two Year Imatinib Treatment in Adjuvant Gastrointestinal Stromal Tumor (GIST)NCT01172548
Gastrointestina...
imatinib mesyla...
18 Years - Novartis
Comparaison Between MRI Alone or Combined With Positron Emission Tomography for Brain Metastasis DiagnosisNCT05095766
Brain Metastase...
18 Years - Centre de recherche du Centre hospitalier universitaire de Sherbrooke
Markers of Response to Intravesical Bladder Cancer TherapyNCT01007058
Bladder Cancer
18 Years - M.D. Anderson Cancer Center
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: